LEARNING OBJECTIVES
PRESENTER(S)
- Describe one more component of addiction medicine consultations in the hospital than previously considered
- Incorporate one more component of addiction care into an admission assessment and plan
- Teach a learner two important differences between methadone and buprenorphine
Dale Terasaki, Internist and addiction specialist, MD MPH
Denver Health & Hospital Authority, University of Colorado School of Medicine
Dale Terasaki is an internist and addiction medicine specialist at Denver Health, where he provides addiction consultations in the hospital setting. He is currently engaged in clinical research evaluating interventions for alcohol use disorder and has published articles on buprenorphine inductions and harm reduction. A Colorado Health Service Corps awardee, Dr. Terasaki is focused on providing and improving substance use disorder care in urban, underserved settings. He earned his medical and public health degrees from the University of Washington and completed residency and fellowship training at the University of Colorado.